Bayer fourth in IVD (in vitro diagnostics) market after $1.1 billion acquisition
This article was originally published in Clinica
Executive Summary
Bayer Diagnostics is to buy Chiron's diagnostic division, for $1.1 billion. The acquisition moves Bayer to fourth place overall in the IVD market worldwide, behind Roche Boehringer Mannheim, Abbott Laboratories and Johnson & Johnson.